P209 Risk factors for respiratory exacerbations in the BOLD study. (2nd December 2011)

• Record Type: Journal Article
• Authors: Gnatiuc, L; Coton, S; Buist, S; Kato, B; Mejza, P; Burney, P
• Is Part Of: Thorax. Volume 66(2011)Supplement 4
• Page Start: A152
• Page End: A152
• Publication Date: 2011-12-02
• Subjects: Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2011-201054c.209
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Background: Exacerbations are important clinical events related to long-term outcomes in asthma and Chronic Obstructive Pulmonary Disease (COPD). However their determinants are not fully understood (Hurst et al, 2010). We used the BOLD data to assess the prevalence and risk factors for respiratory exacerbations among population-based samples of adults aged 40+ across 18 BOLD sites. Methods: Exacerbations were defined as at least one reported episode of breathing problems that interfered with usual daily activities or led to missing work in the previous 12 months. Multiple logistic regressions were used to estimate the effects of potential risk factors for reported exacerbations: medical history, FVC, occupational, biomass and smoking exposures, education, age and sex. All effects were mutually adjusted and estimated using probability weights to allow for the sampling design. Regression models were fitted separately for each centre before pooling results across centres using random effects meta-analysis. Heterogeneity was summarised using the I 2 statistic. Results: The 12-month prevalence of reported exacerbations ranged from 1.9% in Guangzhou, China to 14.2% in Lexington, USA, it was higher in subjects with spirometrically defined COPD as compared to subjects without spirometric COPD (14.4% vs 4.2%, p<0.0001) and in low and middle income countries as compared to high income countries (7.9% vs 4.9%, p<0.0001). Exacerbations were associated with doctor diagnosed asthma, COPD stage 1+, chronic bronchitis, increase in MMRC dyspnoea score, current exposures to biomass and dusty jobs and history of TB (see Abstract P209 table 1 ). Similar trends for overall effect estimates were obtained for low and middle income countries and high income countries with and without biomass exposure information. The variation in reported exacerbations across sites is unlikely to be due to variation in the influence of different risk factors between sites except for COPD stages 1 and 2 (I 2 =44%, p=0.03), biomass exposure (I 2 =57%, p=0.01) and reported history of TB (I 2 =65.2%, p=0.001). Conclusion: Respiratory exacerbations commonly occur in those with normal ventilatory function. Exacerbations are associated with severity of COPD, doctor diagnosed asthma, and environmental exposure to biomass and workplace dust. Chronic cough and phlegm and a diagnosis of emphysema are also associated with an increased risk for exacerbation in people with and without irreversible airway obstruction.